Dearest Readers, we have a confession to make. We fell short of the sacred trust you have placed in us, and were, somehow remiss. You see, it seems, that other than to mention an index change, we never discussed Air Products and Chemicals (APD) October 2016 spinoff of Versum Materials (VSM). We apologize profusely for this breach and… Read More »
Humans are nothing if not pattern recognition machines. Even in random data, we see patterns. So Bloomberg’s report that Jorge Paulo Lemann’s 3G is expected by some to be ready to do another large deal is no surprise. Never mind that the supposition is based on a mere two data points: two years separated 3G’s 2013 acquisition of… Read More »
Bill Ackman loved its business model of purchasing companies with “mispriced” drugs and raising prices, but, under fire from regulators and legislators, Valeant(VRX) announced today that it will be completely changing its business model. Recent outrage about huge price increases for acquired drugs including public statements by Democratic Presidential candidate Hillary Clinton have been a cause of the… Read More »